[Skip to Navigation]
Clinical Note
May 16, 2011

An Infantile Bronchial Hemangioma Unresponsive to Propranolol Therapy: Case Report and Literature Review

Author Affiliations

Author Affiliations: Rosalind Franklin University of Medicine and Science, North Chicago, Illinois (Mssrs Sierpina and Chaudhary); and Divisions of Pediatric Otolaryngology (Dr Walner), Pulmonology (Dr Aljadeff), and Cardiology (Dr Dubrow), Lutheran General Children's Hospital, Park Ridge, Illinois.

Arch Otolaryngol Head Neck Surg. 2011;137(5):517-521. doi:10.1001/archoto.2011.67

Current options for treating airway hemangiomas include systemic and intralesional corticosteroids, interferon therapy, chemotherapy, use of lasers, open surgical excision, tracheotomy, sleeve resection, and selective artery embolization. The significant rates of complications described for these methods1,2 make the discovery of a novel therapy an attractive prospect. Several case reports and case series3-9 have recently appeared in the literature describing the use of propranolol as a highly effective option for the treatment of these airway lesions. Therefore, we reviewed the literature for information on the management of airway hemangiomas by performing a comprehensive PubMed search, focusing particularly on the use of propranolol in the treatment of airway hemangiomas, defined as occurring in the subglottis, trachea, and/or bronchi. We also describe a a 3-month-old boy with a large bronchial hemangioma that did not respond to propranolol therapy.

Add or change institution